首页> 外文期刊>Pharmacognosy magazine >Role of Adiantum philippense L. on Glucose Uptake in Isolated Pancreatic Cells and Inhibition of Adipocyte Differentiation in 3T3-L1 Cell Line
【24h】

Role of Adiantum philippense L. on Glucose Uptake in Isolated Pancreatic Cells and Inhibition of Adipocyte Differentiation in 3T3-L1 Cell Line

机译:铁线蕨对离体胰腺细胞摄取葡萄糖的作用及对3T3-L1细胞株脂肪细胞分化的抑制作用

获取原文
           

摘要

Background: Adiantum philippense (AP) is a pteridophyte that shows antihyperglycemic activity in vivo diabetic model, but the mechanism of action is unknown. Objective: AP was found to play a pivotal role in minimizing the high blood glucose in alloxan-induced diabetic rats. Simultaneously, it was observed that it could maintain the normal lipid profile even in diabetic condition. To investigate its insulin-like activity along with its inhibitory role on adipocyte differentiation became the objective of our present study. Materials and Methods: Glucose uptake potential of this fern was done in isolated pancreatic islets and inhibition of adipocyte differentiation was assessed in 3T3-L1 cell line. Before this, the cytotoxic concentration was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay on L929 cell line. To determine its role in lipid metabolism, the oil droplets produced in adipocytes were stained with Oil ‘O’ red staining, and triglyceride levels of various drug treatments were measured spectrophotometrically. Results: This fern extract was found to be actively utilizing glucose in the glucose uptake assay. Moreover, it was also involved in inhibiting differentiation of pro-adipocyte to adipocyte in the 3T3-L1 cell lines. The percentage inhibition as obtained from the absorbance showed that the ethanolic extract at the concentration of 200 μg/ml showed 32.48% inhibition. Conclusion: All the above-mentioned parameters when appraised indicated that this fern could be used as an alternative medicine in managing diabetes associated with obesity. SUMMARY Adiantum phillippense (AP) is a pteridophyte that can work as antihyperglycemic agent by minimizing some adverse effects produced by diabetes. Diabetes produces oxidative stress, hampers normal glucose uptake in the pancreas, promotes adipocyte differentiation, and leads to obesity, and as a result, it generates catastrophic effect to the normal cells. The present study has shown that ethanolic extract of AP gives better protection rate against H2 O2-induced cytotoxicity, elicits insulinotropic activity in isolated mouse pancreatic glucose uptake assay. It also inhibits the preadipocytes to become mature adipocytes judged by morphology or lipid-specific Oil-Red-O staining of 3T3-L1 cell line. Abbreviations used: AP: Adiantum phillipense; MTT: (3-(4,5- Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide); BSA: Bovine serum albumin; FCS: Fetal calf serum; DMEM: Dulbecco's minimum essential media; RPMI: Roswell park memorial institute medium; DTZ: Dithizone; TG: Triglyceride; PPARγ: Peroxisome proliferator-activated receptor gamma; IBMX: 3-isobutyl-1-methylxanthine; nm: Nanometer; GI: Growth Inhibition; ELISA: Enzyme linked immunosorbent assay.
机译:背景:铁线蕨(Adiantum philippense,AP)是一种蕨类植物,在体内糖尿病模型中具有抗高血糖活性,但其作用机理尚不清楚。目的:发现AP在降低四氧嘧啶致糖尿病大鼠的高血糖中起关键作用。同时,观察到即使在糖尿病条件下也可以维持正常的脂质分布。研究其胰岛素样活性及其对脂肪细胞分化的抑制作用成为我们目前研究的目的。材料和方法:该蕨类植物的葡萄糖摄取潜力在分离的胰岛中完成,并在3T3-L1细胞系中评估了脂肪细胞分化的抑制作用。在此之前,通过在L929细胞系上通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑鎓溴化物测定来确定细胞毒性浓度。为了确定其在脂质代谢中的作用,将脂肪细胞中产生的油滴用“ O”油染色,并用分光光度法测量各种药物处理的甘油三酯水平。结果:发现该蕨提取物在葡萄糖摄取测定中正在积极利用葡萄糖。此外,它还参与抑制3T3-L1细胞系中的前脂肪细胞向脂肪细胞的分化。从吸光度获得的抑制百分数显示,浓度为200μg/ ml的乙醇提取物显示出32.48%的抑制作用。结论:上述所有参数均经过评估,表明该蕨类植物可作为治疗肥胖相关糖尿病的替代药物。发明内容铁线蕨(AP)是一种蕨类植物,可以通过最大程度地减少糖尿病产生的一些不良作用而作为降糖药。糖尿病产生氧化应激,阻碍胰腺中正常葡萄糖的摄取,促进脂肪细胞分化,并导致肥胖,其结果对正常细胞产生灾难性影响。本研究表明,AP乙醇提取物对H 2 O 2 诱导的细胞毒性具有更好的保护作用,在离体小鼠胰腺葡萄糖摄取试验中具有促胰岛素活性。通过3T3-L1细胞系的形态或脂质特异性Oil-Red-O染色判断,它还抑制前脂肪细胞成为成熟的脂肪细胞。使用的缩写:AP:铁线铁线蕨; MTT:(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑鎓); BSA:牛血清白蛋白; FCS:胎牛血清; DMEM:Dulbecco的基本必需媒体; RPMI:罗斯威尔公园纪念学院; DTZ:双硫zone; TG:甘油三酸酯; PPARγ:过氧化物酶体增殖物激活的受体γ; IBMX:3-异丁基-1-甲基黄嘌呤; nm:纳米; GI:生长抑制; ELISA:酶联免疫吸附测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号